These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32273709)

  • 1. The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer's Disease Population.
    Shi Q; Zhou F; Mei J; Yang H; Li H
    Neuropsychiatr Dis Treat; 2020; 16():829-836. PubMed ID: 32273709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors for depression in Alzheimer's disease patients.
    Yang H; Hong W; Chen L; Tao Y; Peng Z; Zhou H
    Int J Neurosci; 2020 Nov; 130(11):1136-1141. PubMed ID: 32053409
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (J-BIRD).
    Kabeshita Y; Adachi H; Matsushita M; Kanemoto H; Sato S; Suzuki Y; Yoshiyama K; Shimomura T; Yoshida T; Shimizu H; Matsumoto T; Mori T; Kashibayashi T; Tanaka H; Hatada Y; Hashimoto M; Nishio Y; Komori K; Tanaka T; Yokoyama K; Tanimukai S; Ikeda M; Takeda M; Mori E; Kudo T; Kazui H
    Int J Geriatr Psychiatry; 2017 Feb; 32(2):222-230. PubMed ID: 27001907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.
    Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Bernardini S; Placidi F
    J Alzheimers Dis; 2018; 66(3):993-999. PubMed ID: 30372684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease.
    Hwang I; Baek KH; Han JH; Ha SW; Yang Y
    Dement Neurocogn Disord; 2017 Sep; 16(3):78-82. PubMed ID: 30906375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
    Cummings JL; Koumaras B; Chen M; Mirski D;
    Am J Geriatr Pharmacother; 2005 Sep; 3(3):137-48. PubMed ID: 16257816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in presentation of behavioral and psychological symptoms in Alzheimer's disease in Taiwan.
    Hsieh SW; Chen CH; Huang LC; Chang YH; Yang YH
    Aging Ment Health; 2020 Aug; 24(8):1342-1347. PubMed ID: 30912669
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between Sleep Disturbances and Medial Temporal Lobe Volume in Older Adults with Mild Cognitive Impairment Free of Lifetime History of Depression.
    Yuen K; Rashidi-Ranjbar N; Verhoeff NPLG; Kumar S; Gallagher D; Flint AJ; Herrmann N; Pollock BG; Mulsant BH; Rajji TK; Voineskos AN; Fischer CE; Mah L;
    J Alzheimers Dis; 2019; 69(2):413-421. PubMed ID: 31104028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
    Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
    J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease.
    Li W; Wang T; Xiao S
    Neuropsychiatr Dis Treat; 2016; 12():2489-2495. PubMed ID: 27729793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.
    Musa G; Henríquez F; Muñoz-Neira C; Delgado C; Lillo P; Slachevsky A
    Dement Neuropsychol; 2017; 11(2):129-136. PubMed ID: 29213504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.